Work

Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements

Year: 2020

Type: article

Abstract: not available.

Source: SKIN The Journal of Cutaneous Medicine

DOI: 10.25251/skin.4.supp.94

Authors: E Guttman-Yassky, A Blauvelt, L Eichenfield, A Paller, A Armstrong, J Drew, R Gopalan, E Simpson

Institutions: Icahn School of Medicine at Mount Sinai, Oregon Medical Research Center, University of California System, University of California San Diego, Rady Children's Hospital-San Diego, Northwestern University, University of Southern California, Dermira (United States), Oregon Health & Science University

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: Eli Lilly and Company, Dermira

OpenAlex ID: W3102301213

FWCI:

Cites:

Cited by:

Related to: 10